96 related articles for article (PubMed ID: 18344530)
1. In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone.
Dykens JA; Jamieson JD; Marroquin LD; Nadanaciva S; Xu JJ; Dunn MC; Smith AR; Will Y
Toxicol Sci; 2008 Jun; 103(2):335-45. PubMed ID: 18344530
[TBL] [Abstract][Full Text] [Related]
2. The photosensitiser azure A disrupts mitochondrial bioenergetics through intrinsic and photodynamic effects.
de Souza BTL; Klosowski EM; Mito MS; Constantin RP; Mantovanelli GC; Mewes JM; Bizerra PFV; da Silva FSI; Menezes PVMDC; Gilglioni EH; Utsunomiya KS; Marchiosi R; Dos Santos WD; Ferrarese-Filho O; Caetano W; de Souza Pereira PC; Gonçalves RS; Constantin J; Ishii-Iwamoto EL; Constantin RP
Toxicology; 2021 May; 455():152766. PubMed ID: 33775737
[TBL] [Abstract][Full Text] [Related]
3.
El-Kasaby A; Boytsov D; Kasture A; Krumpl G; Hummel T; Freissmuth M; Sandtner W
Mol Pharmacol; 2024 May; ():. PubMed ID: 38769018
[TBL] [Abstract][Full Text] [Related]
4. Risk Assessment of Psychotropic Drugs on Mitochondrial Function Using In Vitro Assays.
Rosell-Hidalgo A; Eakins J; Walker P; Moore AL; Ghafourian T
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137493
[TBL] [Abstract][Full Text] [Related]
5. Multiple mechanisms underlying troglitazone-induced mitochondrial permeability transition.
Okuda T; Norioka M; Shitara Y; Horie T
Toxicol Appl Pharmacol; 2010 Nov; 248(3):242-8. PubMed ID: 20709092
[TBL] [Abstract][Full Text] [Related]
6. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro.
Dykens JA; Jamieson J; Marroquin L; Nadanaciva S; Billis PA; Will Y
Toxicol Appl Pharmacol; 2008 Dec; 233(2):203-10. PubMed ID: 18817800
[TBL] [Abstract][Full Text] [Related]
7. Loss of autophagy in erythroid cells leads to defective removal of mitochondria and severe anemia in vivo.
Mortensen M; Ferguson DJ; Edelmann M; Kessler B; Morten KJ; Komatsu M; Simon AK
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):832-7. PubMed ID: 20080761
[TBL] [Abstract][Full Text] [Related]
8. Involvement of mitochondrial dysfunction in nefazodone-induced hepatotoxicity.
Silva AM; Barbosa IA; Seabra C; Beltrão N; Santos R; Vega-Naredo I; Oliveira PJ; Cunha-Oliveira T
Food Chem Toxicol; 2016 Aug; 94():148-58. PubMed ID: 27288927
[TBL] [Abstract][Full Text] [Related]
9. Current concepts in drug-induced mitochondrial toxicity.
Nadanaciva S; Will Y
Curr Protoc Toxicol; 2009 May; Chapter 2():Unit 2.15. PubMed ID: 20941696
[TBL] [Abstract][Full Text] [Related]
10. The utility of HepG2 cells to identify direct mitochondrial dysfunction in the absence of cell death.
Kamalian L; Chadwick AE; Bayliss M; French NS; Monshouwer M; Snoeys J; Park BK
Toxicol In Vitro; 2015 Jun; 29(4):732-40. PubMed ID: 25746382
[TBL] [Abstract][Full Text] [Related]
11. Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria.
Porceddu M; Buron N; Roussel C; Labbe G; Fromenty B; Borgne-Sanchez A
Toxicol Sci; 2012 Oct; 129(2):332-45. PubMed ID: 22987451
[TBL] [Abstract][Full Text] [Related]
12. New insights in drug-induced mitochondrial toxicity.
Nadanaciva S; Will Y
Curr Pharm Des; 2011; 17(20):2100-12. PubMed ID: 21718246
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Drug-Induced Liver Injury in HepG2 Cells Cultured with Human Liver Microsomes.
Choi JM; Oh SJ; Lee JY; Jeon JS; Ryu CS; Kim YM; Lee K; Kim SK
Chem Res Toxicol; 2015 May; 28(5):872-85. PubMed ID: 25860621
[TBL] [Abstract][Full Text] [Related]
14. Characterizing the mechanism of thiazolidinedione-induced hepatotoxicity: An in vitro model in mitochondria.
Hu D; Wu CQ; Li ZJ; Liu Y; Fan X; Wang QJ; Ding RG
Toxicol Appl Pharmacol; 2015 Apr; 284(2):134-41. PubMed ID: 25727309
[TBL] [Abstract][Full Text] [Related]
15. Multiple compound-related adverse properties contribute to liver injury caused by endothelin receptor antagonists.
Kenna JG; Stahl SH; Eakins JA; Foster AJ; Andersson LC; Bergare J; Billger M; Elebring M; Elmore CS; Thompson RA
J Pharmacol Exp Ther; 2015 Feb; 352(2):281-90. PubMed ID: 25467130
[TBL] [Abstract][Full Text] [Related]
16. Validation of a HTS-amenable assay to detect drug-induced mitochondrial toxicity in the absence and presence of cell death.
Swiss R; Niles A; Cali JJ; Nadanaciva S; Will Y
Toxicol In Vitro; 2013 Sep; 27(6):1789-97. PubMed ID: 23726864
[TBL] [Abstract][Full Text] [Related]
17. Assessment of drug-induced mitochondrial dysfunction via altered cellular respiration and acidification measured in a 96-well platform.
Nadanaciva S; Rana P; Beeson GC; Chen D; Ferrick DA; Beeson CC; Will Y
J Bioenerg Biomembr; 2012 Aug; 44(4):421-37. PubMed ID: 22689143
[TBL] [Abstract][Full Text] [Related]
18. A chemical screen probing the relationship between mitochondrial content and cell size.
Kitami T; Logan DJ; Negri J; Hasaka T; Tolliday NJ; Carpenter AE; Spiegelman BM; Mootha VK
PLoS One; 2012; 7(3):e33755. PubMed ID: 22479437
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of drug-induced liver injury: from bedside to bench.
Tujios S; Fontana RJ
Nat Rev Gastroenterol Hepatol; 2011 Apr; 8(4):202-11. PubMed ID: 21386809
[TBL] [Abstract][Full Text] [Related]
20. Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714.
Feng B; Xu JJ; Bi YA; Mireles R; Davidson R; Duignan DB; Campbell S; Kostrubsky VE; Dunn MC; Smith AR; Wang HF
Toxicol Sci; 2009 Apr; 108(2):492-500. PubMed ID: 19223659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
